ResMed (RMD), St. Jude (STJ), Cepheid (CPHD) Among Med Tech Companies with Most EU Exposure - Needham & Company

Needham & Company analyst Mike Matson highlighted European Exposure among the firm's Med Tech coverage:

They believe that the three companies in their universe with the most exposure to Europe are: RMD (~29% of sales), STJ (~26% of sales), and CPHD (~25%).

They also believe that the three companies in our universe with least exposure to Europe include: GNMK (~0% of sales), CSII (~0% of sales), MDXG (~2% of sales).

In terms of UK exposure, they believe that EXAM is the highest at ~21% of sales.

You May Also Be Interested In

• Needham Reiterates Buy Rating on Amazon.com (AMZN), Raises Estimates
• Needham & Company reiterates Buy rating on Amazon (AMZN), raises estimates
• TScan Therapeutics (TCRX) Launches $125 Million Proposed Public Offering of Common Stock, Warrants